KEZAR LIFE SCIENCES INC's ticker is KZR and the CUSIP is 49372L100. A total of 138 filers reported holding KEZAR LIFE SCIENCES INC in Q1 2023. The put-call ratio across all filers is 0.79 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $225,936 | -37.7% | 72,184 | +40.2% | 0.00% | 0.0% |
| Q4 2022 | $362,553 | -4.3% | 51,499 | +16.9% | 0.00% | 0.0% |
| Q3 2022 | $379,000 | +345.9% | 44,048 | +329.3% | 0.00% | – |
| Q2 2022 | $85,000 | -88.9% | 10,260 | -77.8% | 0.00% | -100.0% |
| Q1 2022 | $768,000 | -36.4% | 46,200 | -36.0% | 0.00% | 0.0% |
| Q4 2021 | $1,207,000 | +224.5% | 72,200 | +67.5% | 0.00% | +100.0% |
| Q3 2021 | $372,000 | +51.8% | 43,100 | -4.6% | 0.00% | 0.0% |
| Q2 2021 | $245,000 | -25.8% | 45,200 | -18.4% | 0.00% | 0.0% |
| Q1 2021 | $330,000 | +17.9% | 55,400 | +3.4% | 0.00% | 0.0% |
| Q4 2020 | $280,000 | +39.3% | 53,600 | +28.8% | 0.00% | 0.0% |
| Q3 2020 | $201,000 | +118.5% | 41,600 | +133.7% | 0.00% | – |
| Q2 2020 | $92,000 | -34.8% | 17,800 | -2.7% | 0.00% | – |
| Q2 2019 | $141,000 | – | 18,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 4,770,799 | $5,677,251 | 1.80% |
| Qiming U.S. Ventures Management, LLC | 828,711 | $986,166 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 7,167,591 | $8,529,433 | 0.46% |
| SPHERA FUNDS MANAGEMENT LTD. | 2,051,676 | $2,441,494 | 0.44% |
| Avidity Partners Management LP | 6,011,100 | $7,153,209 | 0.29% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 703,825 | $830,514 | 0.28% |
| Opaleye Management Inc. | 425,000 | $505,750 | 0.16% |
| Orbimed Advisors | 5,463,000 | $6,500,970 | 0.14% |
| Ikarian Capital, LLC | 853,391 | $1,015,535 | 0.12% |
| Palo Alto Investors LP | 656,200 | $780,878 | 0.07% |